Uptravi 600 mcg

UPTRAVI 600 MCG tablets contain the active ingredient selexipag, used for managing certain cardiovascular conditions. This medication is designed to support heart health and improve circulation.

UPTRAVI 600 MCG tablets are primarily used to treat conditions related to pulmonary arterial hypertension. Selexipag works by relaxing blood vessels, which can help reduce the workload on the heart and improve blood flow. This medication is often prescribed as part of a comprehensive treatment plan for managing symptoms associated with cardiovascular health.

Common effects of UPTRAVI 600 MCG tablets may include headaches, nausea, and dizziness. Some users might also experience diarrhea or fatigue. These effects can vary from person to person and may subside as the body adjusts to the medication.

UPTRAVI 600 MCG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the medication out of reach of children and store it at room temperature unless otherwise directed.

UPTRAVI 600 MCG tablets may interact with certain medications, including those metabolized by the liver's CYP enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.